Son güncelleme :
19/11/2024
Antihipertansif   Lisinopril  
Oral solüsyon / oral çözelti
Farmasötik preparatlar Kararlılığı Karışımlardaki stabilitesi Stabiliteyi etkileyen faktörler Uyumluluk Kaynaklar pdf
   Kimyasal yapı   

Oral solüsyon / oral çözelti
Kaynaklar   Oral solüsyon / oral çözelti   Kaynaklar : Lisinopril  
tip yayın
2389 Dergi Thompson KC, Zhao Z, Mazakas JM, Beasley CA, Reed RA, Moser CL.
Characterization of an extemporaneous liquid formulation of lisinopril
Am J Health-Syst Pharm 2003 ; 60: 69-74.
2549 Dergi Nahata MC, Morosco RS.
Stability of Lisinopril in Two Liquid Dosage Forms
Ann Pharmacotherapy 2004 ;38:396-399.
2665 Dergi Webster AA, English BA, Rose DJ.
The stability of lisinopril as an extemporaneous syrup.
Int J Pharm Compound 1997 ; 1: 352-353.
2680 Dergi Rose DJ, Webster AA, English BA.
Stability of lisinopril syrup (2 mg/ml) extemporaneously compounded from tablets.
Int J Pharm Compound 2000 : 398-399.
3902 Dergi Polonini Hudson C, Loures Sharlene,de Araujo Edson Peter, Brand?o Marcos Ant?nio F, Ferreira Anderson O.
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions.
Int J Pharm Compound 2016 ; 20, 5 : 426-434.

  Mentions Légales